LIFNano Therapeutics  

First-in-class brain-healing company

OWNER

Olivier Jarry (See Profile)

Sector

Nanotechnology

Stage

Prototyping, preclinical

Country

UK

Suppressing inflammation and promoting neuro-immune quiescence

No known therapy matches LIFNano's compound triple action

High potency - single dose in vivo efficacious for neuroprotection in Gold Standard models

Bulk manufacture, long-term storage, global distribution

Clinical Trials of product's components confirm safety

This information is confidential, do not share or copy.

You can visit their website or

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2019 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar